why choose us

First received: August 7, 2022

Clinical Trial: Real World Study on the Use of Cemiplimab in Adult Patients in UK

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Cutaneous Squamous Cell Carcinoma

Study Type: Observational


Official Title: Real-world Evidence Study on the Early Use of Cemiplimab in the UK: REACT-CEMI (Real World Evidence of Advanced CSCC Treatment - With CEMIplimab)

Brief Summary: The primary objective is to describe the real-world clinical effectiveness of cemiplimab in patients with locally advanced cutaneous squamous cell carcinoma (laCSCC) or metastatic cutaneous squamous cell carcinoma (mCSCC) treated in routine clinical practice.

Read more